Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (281-290 of 918) with videos related to

Pageof 92
Sort By:
BJU International|October 16, 2016
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomyDerya Tilki, Felix Preisser, Pierre Tennstedt, et al.
International Urology and Nephrology|September 23, 2019
External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patientsSophie Knipper, Cristina Dzyuba-Negrean, Carlotta Palumbo, et al.
Journal of Endourology|February 26, 2008
Lower urinary tract symptoms affect one-third of men in a prostate cancer screening populationJochen Walz, Nazareno Suardi, Georg C Hutterer, et al.
Prostate Cancer and Prostatic Diseases|August 21, 2020
Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancerFelix Preisser, Giorgio Gandaglia, Farid Arad, et al.
World Journal of Urology|March 2, 2018
Validation of the current eligibility criteria for focal therapy in men with localized prostate cancer and the role of MRIRaisa S Pompe, Bieke Kühn-Thomä, Yamini Nagaraj, et al.
Urology|September 7, 2012
Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomyJens Hansen, Lars Budäus, Jan Spethmann, et al.
Urologic Oncology|May 27, 2019
Contemporary clinicopathological characteristics of pT0 prostate cancer at radical prostatectomy: A population-based studySophie Knipper, Derya Tilki, Elio Mazzone, et al.
European Urology|June 21, 2002
Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancerR Jüri Palisaar, Markus Graefen, Pierre I Karakiewicz, et al.
Urology|July 3, 2003
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screeningMichael Aleman, Pierre I Karakiewicz, Patrick Kupelian, et al.
BJU International|March 12, 2014
The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based studyGiorgio Gandaglia, Maxine Sun, Ioana Popa, et al.
Pageof 92

Showing results (281-290 of 918) with videos related to

Sort By:
Pageof 92
BJU International|October 16, 2016
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomyDerya Tilki, Felix Preisser, Pierre Tennstedt, et al.
International Urology and Nephrology|September 23, 2019
External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patientsSophie Knipper, Cristina Dzyuba-Negrean, Carlotta Palumbo, et al.
Journal of Endourology|February 26, 2008
Lower urinary tract symptoms affect one-third of men in a prostate cancer screening populationJochen Walz, Nazareno Suardi, Georg C Hutterer, et al.
Prostate Cancer and Prostatic Diseases|August 21, 2020
Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancerFelix Preisser, Giorgio Gandaglia, Farid Arad, et al.
World Journal of Urology|March 2, 2018
Validation of the current eligibility criteria for focal therapy in men with localized prostate cancer and the role of MRIRaisa S Pompe, Bieke Kühn-Thomä, Yamini Nagaraj, et al.
Urology|September 7, 2012
Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomyJens Hansen, Lars Budäus, Jan Spethmann, et al.
Urologic Oncology|May 27, 2019
Contemporary clinicopathological characteristics of pT0 prostate cancer at radical prostatectomy: A population-based studySophie Knipper, Derya Tilki, Elio Mazzone, et al.
European Urology|June 21, 2002
Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancerR Jüri Palisaar, Markus Graefen, Pierre I Karakiewicz, et al.
Urology|July 3, 2003
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screeningMichael Aleman, Pierre I Karakiewicz, Patrick Kupelian, et al.
BJU International|March 12, 2014
The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based studyGiorgio Gandaglia, Maxine Sun, Ioana Popa, et al.
Pageof 92